People news: Biocodex USA and 3-V Biosciences

Share this article:
Biocodex USA hired Dr. Andres Tellez as principal, business development and strategy, responsible for in-licensing or acquiring new therapeutics to market for the US subsidiary of Biocodex, a French pharmaceutical firm.

3-V Biosciences promoted Stephen Brady to chief business officer. Brady joined the firm in 2010 as VP, corporate development, strategy & operations, with management responsibility for the company's business functions. Prior to joining 3-V, he was VP of corporate development for Proteolix. Brady also worked at Lexicon Pharmaceuticals, where he served in business development, communications and corporate legal capacities, and was a VP with Lazard Venture Advisors, a division of Lazard Freres & Co.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions